This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jul. 4, 2013

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

REGISTER TODAY
Fall Managed Care Forum
Nov. 14-15
Las Vegas

Click here to view the following free CME/CEU program:
Overcoming Challenges in the Management of Obesity: A Closer Look at Emerging Therapeutic Options.

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The FDA has recently approved Skyla, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy. Click here to view the Press Release in PDF Format!

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

Observing live gene expression in the body
ScienceDaily
Most of our physiological functions fluctuate throughout the day. They are coordinated by a central clock in the brain and by local oscillators, present in virtually every cell. Many molecular gearwheels of this internal clock have been described by Ueli Schibler, professor at the Faculty of Science of the University of Geneva, Switzerland. To study how the central clock synchronizes subordinate oscillators, the researcher's group used a variety of genetic and technological tools developed in collaboration with a team of UNIGE physicians.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




5 reasons not to do genetic testing
Medscape
There can be little doubt that the future of medicine, the next penicillin if you will, is genomics. Why wouldn't it be? The double helix forms the foundation of biology. Already, great strides have been made. During the plenary session at the 2013 Heart Rhythm Society Sessions, President Bill Clinton boasted that he spent $3 billion to sequence the human genome. Now, it can be done for thousands. Personal genomic medicine has arrived. And so has the entrepreneur.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Vitamin C influences gene activity in stem cells
Medical News Today
A study of mouse stem cells reveals that vitamin C may play a role in their health by influencing the switching on and off of genes. The researchers suggest this could have an important effect on the development of mice, humans and other animals, and finding out more about the underlying mechanisms could improve our understanding of in vitro fertilization, cancer and adult stem cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


How biotechs got hot
The Wall Street Journal
Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes last year that make it easier for companies to gauge investor interest in a potential IPO.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Healthcare Professionals Save with Sprint

Switch to Sprint and save. Healthcare professionals can save at least 15% monthly with Sprint. Sprint offers special promotions for healthcare employees. With Sprint, you save more and get Truly UnlimitedSM data. Visit www.sprint.com/daretocompare for more details and to start saving today.
 


Combination of evidence-based medicine and personalized medicine can result in optimal healthcare
New-Medical.net
There are two popular models when it comes to delivering the best healthcare — using evidence-based guidelines or applying personalized medicine. Each method has its own merits and drawbacks, but according to one Northwestern Medicine- cardiologist, when the two theories are integrated the result is an optimal healthcare delivery model that is both less expensive and better for the patient.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword "personalized medicine."


Onyx Pharmaceuticals rejects takeover bid from biotech giant Amgen
Los Angeles Times
Onyx Pharmaceuticals Inc. rejected an unsolicited takeover bid from Amgen Inc., the Thousand Oaks biotech giant. Onyx, headquartered in south San Francisco, confirmed in a statement that it had received a bid of $120 a share from Amgen, but said the offer "significantly undervalued" the company and was "not in the best interest of Onyx or its shareholders."
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


3-D printing could build new bone using stem cells
The Huffington Post
Damaged bones could be fixed with a new technique that involves 3-D printing a tissue using living stem cells. For example, if a child had a jawbone defect, you could take an image of the defect, feed it into a computer and print a replacement to precisely fill the defect using the patient's own cells, said Kevin Shakeshaff, a pharmacist at the University of Nottingham in England.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Genes known to cause birth defects may also lead to mental illness (Fox News)
Surgeon uses Google Glass in the OR to share endoscopic surgery (MedCity News)
Reading DNA, backward and forward: Biologists reveal how cells control the direction in which the genome is read (ScienceDaily)
US unveils healthcare website and call center (The New York Times)

Don't be left behind. Click here to see what else you missed.


Scientists discover molecular communication network in human stem cells
Phys.Org
Scientists at A*STAR's Genome Institute of Singapore and the Max Planck Institute for Molecular Genetics in Germany have discovered a molecular network in human embryonic stem cells that integrates cell communication signals to keep the cell in its stem cell state. These findings were reported in the June 2013 issue of Molecular Cell.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Paper raises hundreds of questions about the integrity of stem cell research group
Forbes
Serious questions have been raised about the integrity and validity of research performed by a well-established German stem cell research group. A paper published in the International Journal of Cardiology exhaustively details a multitude of discrepancies and contradictions in papers from the researcher's group.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Doctors need more training on how to use EHRs during patient encounters
iHealthBeat
The use of electronic health records in the exam room need not harm the doctor-patient relationship if physicians use EHRs properly, according to a recent report from the American Medical Association Board of Trustees. But observers raise some serious questions about how EHRs may be changing doctor-patient interaction and about whether physicians are trained well enough to know what they're doing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


6 apps to get a doctor's advice
ITworld
A variety of mobile apps offer free medical tips, verified advice and even consult with medical professionals from your phone. If you want to minimize your time in a waiting room, check out these handy health apps.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
How biotechs got hot
The Wall Street Journal
Biotechnology companies are enjoying their best run with initial public offerings in a decade, amid an upswing in new drug approvals, strong performance by some already public biotech firms and legal changes last year that make it easier for companies to gauge investor interest in a potential IPO.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Study sets guidelines for stem cell transplants in older patients with myelodysplastic syndromes
ScienceDaily
A new study by an international team led by Dana-Farber Cancer Institute scientists provides the first statistically-based guidelines for determining whether a stem cell transplant is appropriate for older patients with myelodysplastic syndromes ...

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Medication misuse costs US $200 billion annually
Clinical Advisor
Misuse of prescription drugs costs the U.S. $200 billion annually, according to a press release by IMS Health regarding a recent study.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MANAGED HEALTHCARE NEWS


Why US healthcare jobs are growing 20 percent faster than any other sector
Quartz
In the last decade, healthcare jobs have grown faster than all other categories of employment — a 22.7 percent increase, compared to 2.1 percent. What gives?
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Why healthcare costs are about to explode
Forbes
Word out of Washington is that Obamacare is finally fulfilling its promise to bend the nation's healthcare cost curve. Unfortunately, it's bending it the wrong way. Forty-one months after its passage, data are beginning to emerge questioning whether the Accountable Care Act can actually provide care to more Americans for less.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




FDA: NEW TREATMENTS AND TECHNOLOGY


FDA takes action against illegal online pharmacies
Pharmaceutical Technology Magazine
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action against more than 9,600 websites that illegally sell potentially dangerous, unapproved prescription medicines to consumers. These actions include the issuance of regulatory warnings, and seizure of offending websites and $41 million worth of illegal medicines worldwide.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA scraps Merck's high-dose sleep drug, demands weaker version
FierceBiotech
Fretting over the potential for serious side effects, the FDA has batted aside Merck's application to sell the new insomnia drug suvorexant, demanding that the pharma giant substitute a significantly weaker dose than the company had wanted to sell.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 27, 2013
June 20, 2013
June 13, 2013
June 6, 2013



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063